Synergistic effects of Deferasirox and Imatinib in chronic myeloid leukemia cells

被引：0
|
作者：
Kim, Dae Sik [1 ]
Kang, Myoung Hee [2 ]
Na, Yoo Jin [2 ]
Kim, Jung Lim [2 ]
Kim, Bo Ram [2 ]
Park, Kyong Hwa [1 ]
Oh, Sang Cheul [1 ]
Seo, Jae Hong [1 ]
Choi, Chul Won [1 ]
Kim, Jun Suk [1 ]
机构：
[1] Dept Internal Med, Div Oncol Hematol, Seoul, South Korea
[2] Korea Univ, Coll Med, Seoul, South Korea
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-5113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5113
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
    Kim, Dae Sik
    Na, Yoo Jin
    Kang, Myoung Hee
    Yoon, Soo-Young
    Choi, Chul Won
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (02): : 357 - 366
  • [2] Synergistic Effects of Inecalcitol With Imatinib and Dasatinib on Chronic Myeloid Leukemia Cell Lines
    Angel, Samuel
    Cowles, Emma
    Costa, Jeams
    AL Ani, Raad
    Venkatachalam, Kallidaikurichi v
    ANTICANCER RESEARCH, 2024, 44 (12) : 5193 - 5197
  • [3] Calcium influx, oxidative stress, and apoptosis induced by TRPV1 in chronic myeloid leukemia cells: Synergistic effects with imatinib
    Maggi, Federica
    Morelli, Maria Beatrice
    Aguzzi, Cristina
    Zeppa, Laura
    Nabissi, Massimo
    Polidori, Carlo
    Santoni, Giorgio
    Amantini, Consuelo
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [4] Chronic myeloid leukemia in the imatinib era
    Druker, BJ
    SEMINARS IN HEMATOLOGY, 2003, 40 (02) : 1 - 3
  • [5] Imatinib in Chronic Myeloid Leukemia: an Overview
    Sacha, Tomasz
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01)
  • [6] Imatinib in chronic myeloid leukemia - Reply
    Druker, Brian
    Gathmann, Insa
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (17): : 1780 - 1780
  • [7] Imatinib Mesylate in Chronic Myeloid Leukemia
    Mishra, Pravas
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 5 - 6
  • [8] Imatinib therapy in chronic myeloid leukemia
    Crossman, LC
    O'Brien, SG
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (03) : 605 - +
  • [9] CYTOTOXIC AND CYTOSTATIC EFFECTS OF PONATINIB ON IMATINIB-SENSITIVE AND -RESISTANT CHRONIC MYELOID LEUKEMIA CELLS
    Yandim, M. Kartal
    Baran, Y.
    LEUKEMIA RESEARCH, 2014, 38 : S55 - S55
  • [10] Differential Effects of Imatinib and Dasatinib On Immune Effector Cells in Patients with Chronic Myeloid Leukemia (CML)
    Rohon, Peter
    Porkka, Kimmo
    Mustjoki, Satu
    BLOOD, 2009, 114 (22) : 1272 - 1272
12345